Infectious Diseases 1601 - Infectious Disease Alert - Jan 01, 2012

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
br / University of Colorado
Denver Health Medical Center

Associate Editors
Hal B. Jenson, MD, FAAP
Dean, Western Michigan University School of Medicine
Kalamazoo, Michigan

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine

Author
Lin H. Chen, MD
Assistant Clinical Professor
Harvard Medical School; Director
Travel Medicine Center
Mt. Auburn Hospital
Cambridge, MA

Subjects:

  • European measles outbreaks continue: Past gains lost to vaccine objections
  • Cytomegalovirus Persists on Surfaces, Posing Risk during Pregnancy
  • A Reassurring Analysis on the Safety of Efavirenz in Pregnancy
  • Physician Protect Thyself (and Your Patients and Coworkers)!
  • B-lactam/B-lactamase Inhibitors for Treatment of Bacteremia due to ESBL-producing E.coli
  • Fever in Travelers After Visiting Malaria-endemic Areas
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, Associate Editor Hal B. Jenson, MD, FAAP, and Author Lin H. Chen, MD, report no financial relationship relavent to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, is a speaker for Cubist Pharmaceuticals and GSK, and is a consultant for Siemens Diagnostics.

Copyright 2012 AHC Media. All rights reserved.